News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) is Banking on Therapeutics as Device Biz Growth Slows



10/14/2013 10:31:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson has traditionally had a strong medical device and diagnostics sectors but the growth in both of those areas has slowed. In the second quarter of 2013, the device segment grew at a rate of 0.5%—ignoring the Synthes acquisition and currency fluctuations. The company is rumored to be mulling the sale of its Ortho Clinical Diagnostics division. Still, the device diagnostic segments are vital for the firm, compromising 41% of its 2012 revenue.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES